Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2024-0253

2. Registrant Information.

Registrant Reference Number: FMC-58214

Registrant Name (Full Legal Name no abbreviations): FMC of Canada Limited

Address: 6755 Mississauga Road, Suite 204

City: Mississauga

Prov / State: Ontario

Country: Canada

Postal Code: L5N7Y2

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No. 22346      PMRA Submission No.       EPA Registration No. 279-3460

Product Name: Clomazone Technical

• Active Ingredient(s)
  • CLOMAZONE

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Clomazone: A Dietary Two-Generation Reproductive Toxicity Study in Sprague Dawley Rats

Date 12-OCT-22

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

FMC Corp. have recently co-sponsored a 2-Generation reproduction toxicity study in Sprague Dawley rats conducted with Clomazone Technical, EPA Reg. No. 279-3460, as well as a position paper pertaining to this study report.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here